» Articles » PMID: 7501116

Steroid Hormone Receptors in Astrocytic Neoplasms

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 1995 Sep 1
PMID 7501116
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of specific steroid hormone-binding receptors has been correlated with the clinical response to hormonal therapy in a number of different neoplasias, including breast and prostate cancer. In this article, we investigated the expression of the androgen, estrogen, glucocorticoid, and progesterone receptor messenger ribonucleic acid (mRNA) and protein in a number of astrocytic neoplasms of various histological grades. Androgen and glucocorticoid receptor mRNA were detected in all astrocytic neoplasms examined, regardless of histological subtype. In contrast, progesterone receptor mRNA was observed more frequently in high-grade tumors than in low-grade tumors. Estrogen receptor mRNA was undetectable in all astrocytic tumors examined. These studies suggest a possible adjunct clinical use of hormonal therapy for the treatment of astrocytomas. Specific antagonists and agonists may allow the modulation of the growth of these tumors. Development of this body of knowledge may lead to the development of better treatment for these aggressive tumors.

Citing Articles

The prognostic significance of androgen receptor expression in gliomas.

Zhao N, Khan R, Hung M, Zhang C, Wang S, Wang T Sci Rep. 2024; 14(1):22122.

PMID: 39333688 PMC: 11437163. DOI: 10.1038/s41598-024-72284-4.


Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma.

Pratap U, Tidwell M, Balinda H, Clanton N, Yang X, Viswanadhapalli S Mol Cancer Ther. 2023; 22(11):1248-1260.

PMID: 37493258 PMC: 10811744. DOI: 10.1158/1535-7163.MCT-23-0031.


Effect of the Use of Gnrh Analogs in Low-Grade Cerebral Glioma.

de Lucio Delgado A, Rubio J, Riano-Galan I, Perez Gordon J Children (Basel). 2023; 10(1).

PMID: 36670665 PMC: 9856414. DOI: 10.3390/children10010115.


Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells.

Lee J, Troike K, Fodor R, Lathia J Endocrinology. 2022; 163(3).

PMID: 35023543 PMC: 8807164. DOI: 10.1210/endocr/bqac002.


Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma.

Zhao N, Wang F, Ahmed S, Liu K, Cathcart S, DiMaio D Front Oncol. 2021; 11:616625.

PMID: 34094902 PMC: 8175980. DOI: 10.3389/fonc.2021.616625.